Prosecution Insights
Last updated: August 18, 2026

Examiner: MAYHEW, BRADLEY SCOTT

Tech Center 1600 • Art Units: 1621

This examiner grants 0% of resolved cases

Performance Statistics

Allow Rate
-60.0% vs TC avg
8
Total Applications
Interview Lift
0
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
12.5%
§102 Novelty
37.5%
§103 Obviousness
31.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18557667 ARYL 3-OXOPIPERAZINE CARBOXAMIDES AND HETEROARYL 3-OXOPIPERAZINE CARBOXAMIDES AS NAV1.8 INHIBITORS Non-Final OA Merck Sharp & Dohme LLC
18256036 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE Non-Final OA IDEMITSU KOSAN CO.,LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month